Madorra
Portland, US · 6 known investors
Madorra develops a nonhormonal, noninvasive medical device to treat vaginal dryness and vulvovaginal atrophy, targeting post-menopausal people and breast cancer survivors. The company operates in the women's health medical device sector and has received FDA breakthrough device designation.
Founders & leadership
HR
Holly Rockweiler
Investors · 6
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $300K |
| National Science Foundation | Phase II | 2017 | $750K |
| National Science Foundation | Phase I | 2016 | $149.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Madorra do?
- Madorra develops a nonhormonal, noninvasive medical device to treat vaginal dryness and vulvovaginal atrophy, targeting post-menopausal people and breast cancer survivors. The company operates in the women's health medical device sector and has received FDA breakthrough device designation.
- Who founded Madorra?
- Madorra was founded by Holly Rockweiler.
- Who are Madorra's investors?
- Madorra's investors include Berkeley Catalyst, Portfolia, Portland Seed Fund, Social Starts, Elevate Capital, OneVentures.
- Where is Madorra headquartered?
- Madorra is headquartered in Portland, US.